Viridian Therapeutics Inc (VRDN)

Apr 26, 2025

Analysts Set Viridian Therapeutics, Inc. (NASDAQ:VRDN) PT at $35.70 - Defense World

Apr 26, 2025

Apr 25, 2025

HC Wainwright Reiterates Buy Rating for Viridian Therapeutics (NASDAQ:VRDN) - Defense World

Apr 25, 2025

Apr 24, 2025

Viridian Therapeutics Inc [VRDN] Shares Fall -1.82 % on Wednesday - knoxdaily.com

Apr 24, 2025

Apr 24, 2025

How did Viridian Therapeutics Inc (VRDN) fare last session? - uspostnews.com

Apr 24, 2025

Apr 18, 2025

Viridian Therapeutics, Inc. (NASDAQ:VRDN) Shares Sold by JPMorgan Chase & Co. - Defense World

Apr 18, 2025

Apr 17, 2025

Geode Capital Management LLC Has $31.81 Million Position in Viridian Therapeutics, Inc. (NASDAQ:VRDN) - Defense World

Apr 17, 2025

Apr 15, 2025

Thyroid Eye Disease Market Predicted to See Upsurge Through - openPR.com

Apr 15, 2025

Apr 15, 2025

Retinitis Pigmentosa Market Growth to Accelerate in Forecast - openPR.com

Apr 15, 2025

Apr 15, 2025

Retinitis Pigmentosa Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes | SparingVision SAS, ProQR Therapeutics NV, Viridian Therapeutics Inc, 4D Molecular Therapeutics - Barchart.com

Apr 15, 2025

Apr 11, 2025

Sector Update: Health Care - TradingView

Apr 11, 2025

Apr 11, 2025

Graves Ophthalmopathy Therapeutics Market Size in 7MM - openPR.com

Apr 11, 2025

Apr 10, 2025

Viridian Therapeutics, Inc. (NASDAQ:VRDN) Stock Position Lifted by Vanguard Group Inc. - Defense World

Apr 10, 2025

Apr 09, 2025

American Century Companies Inc. Has $2.18 Million Position in Viridian Therapeutics, Inc. (NASDAQ:VRDN) - Defense World

Apr 09, 2025

Apr 08, 2025

KLP Kapitalforvaltning AS Acquires New Stake in Viridian Therapeutics, Inc. (NASDAQ:VRDN) - Defense World

Apr 08, 2025

Apr 07, 2025

Viridian Therapeutics Appoints Jeff Ajer To Board - citybiz

Apr 07, 2025

Apr 07, 2025

Viridian Therapeutics Appoints Jeff Ajer to its Board of Directors - BioSpace

Apr 07, 2025

Apr 07, 2025

Viridian Therapeutics Appoints Jeff Ajer to Board - TipRanks

Apr 07, 2025

Apr 07, 2025

Viridian Therapeutics appoints Jeff Ajer to board - Investing.com

Apr 07, 2025

Apr 07, 2025

Viridian Therapeutics appoints Jeff Ajer to board By Investing.com - Investing.com UK

Apr 07, 2025

Apr 07, 2025

Viridian Therapeutics, Inc. (NASDAQ:VRDN) Shares Purchased by Corebridge Financial Inc. - Defense World

Apr 07, 2025

Apr 04, 2025

Stifel maintains Buy on Viridian Therapeutics, $41 target By Investing.com - Investing.com Canada

Apr 04, 2025

Apr 03, 2025

(VRDN) Trading Report - news.stocktradersdaily.com

Apr 03, 2025

Apr 02, 2025

Teacher Retirement System of Texas Boosts Stock Position in Viridian Therapeutics, Inc. (NASDAQ:VRDN) - Defense World

Apr 02, 2025

Apr 01, 2025

Financial Analysis: Viridian Therapeutics (NASDAQ:VRDN) versus ACI Global (OTCMKTS:ACGJ) - Defense World

Apr 01, 2025

Mar 31, 2025

Quantbot Technologies LP Invests $164,000 in Viridian Therapeutics, Inc. (NASDAQ:VRDN) - Defense World

Mar 31, 2025

Mar 28, 2025

Viridian Therapeutics, Inc. (NASDAQ:VRDN) Shares Acquired by Swiss National Bank - Defense World

Mar 28, 2025

Mar 25, 2025

Raymond James Financial Inc. Makes New $6.02 Million Investment in Viridian Therapeutics, Inc. (NASDAQ:VRDN) - Defense World

Mar 25, 2025

Mar 24, 2025

Where are the Opportunities in (VRDN) - news.stocktradersdaily.com

Mar 24, 2025

Mar 22, 2025

Charles Schwab Investment Management Inc. Raises Stock Position in Viridian Therapeutics, Inc. (NASDAQ:VRDN) - Defense World

Mar 22, 2025

Mar 21, 2025

AlphaQuest LLC Acquires 1,519 Shares of Viridian Therapeutics, Inc. (NASDAQ:VRDN) - Defense World

Mar 21, 2025

Mar 20, 2025

Commit To Buy Viridian Therapeutics At $12.50, Earn 13.2% Annualized Using Options - Nasdaq

Mar 20, 2025

Mar 20, 2025

Viridian Therapeutics, Inc. (NASDAQ:VRDN) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World

Mar 20, 2025

Mar 19, 2025

Viridian Therapeutics, Inc. (NASDAQ:VRDN) Shares Purchased by Bank of New York Mellon Corp - Defense World

Mar 19, 2025

Mar 16, 2025

Viridian Therapeutics, Inc. (NASDAQ:VRDN) Shares Bought by Arizona State Retirement System - Defense World

Mar 16, 2025

Mar 15, 2025

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Mar 15, 2025

Mar 15, 2025

410,440 Shares in Viridian Therapeutics, Inc. (NASDAQ:VRDN) Acquired by Victory Capital Management Inc. - Defense World

Mar 15, 2025

Mar 12, 2025

Viridian Therapeutics at Leerink’s Conference: Progress in TED Treatments By Investing.com - Investing.com UK

Mar 12, 2025

Mar 10, 2025

Viridian Therapeutics appoints new director, sees board resignation By Investing.com - Investing.com South Africa

Mar 10, 2025

Mar 10, 2025

Viridian Therapeutics Announces Inducement Stock Option Grants - Nasdaq

Mar 10, 2025

Mar 10, 2025

Viridian Therapeutics appoints new director, sees board resignation - Investing.com India

Mar 10, 2025

Mar 06, 2025

What is B. Riley’s Forecast for VRDN Q1 Earnings? - Defense World

Mar 06, 2025

Mar 05, 2025

Principal Financial Group Inc. Has $3.42 Million Stock Position in Viridian Therapeutics, Inc. (NASDAQ:VRDN) - Defense World

Mar 05, 2025

Mar 05, 2025

What is B. Riley’s Estimate for VRDN Q2 Earnings? - Defense World

Mar 05, 2025

Mar 04, 2025

Decoding Viridian Therapeutics Inc (VRDN): A Strategic SWOT Insi - GuruFocus.com

Mar 04, 2025

Mar 04, 2025

Viridian Therapeutics inks new $300M sales agreement By Investing.com - Investing.com South Africa

Mar 04, 2025

Mar 04, 2025

Viridian Therapeutics Terminates Prior $175 Million Sale Agreement -March 04, 2025 at 06:36 am EST - Marketscreener.com

Mar 04, 2025

Mar 04, 2025

Viridian Therapeutics Enters New $300M Sale Agreement - TipRanks

Mar 04, 2025

Mar 04, 2025

Viridian Therapeutics inks new $300M sales agreement - Investing.com

Mar 04, 2025

Mar 04, 2025

Rhumbline Advisers Has $1.92 Million Holdings in Viridian Therapeutics, Inc. (NASDAQ:VRDN) - Defense World

Mar 04, 2025